Empowered Funds LLC Has $9.41 Million Stake in Danaher Corporation $DHR

Empowered Funds LLC grew its position in Danaher Corporation (NYSE:DHR) by 73.3% during the first quarter, HoldingsChannel.com reports. The firm owned 49,650 shares of the conglomerate’s stock after buying an additional 21,000 shares during the quarter. Empowered Funds LLC’s holdings in Danaher were worth $9,414,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of the company. JPL Wealth Management LLC acquired a new position in Danaher during the third quarter worth $25,000. Main Street Group LTD bought a new position in Danaher in the first quarter valued at $25,000. WFA of San Diego LLC acquired a new stake in Danaher in the 2nd quarter valued at $26,000. Elevated Capital Advisors LLC acquired a new stake in Danaher in the 4th quarter valued at $26,000. Finally, Hilton Head Capital Partners LLC bought a new stake in Danaher during the 4th quarter worth about $27,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. Rothschild & Co Redburn set a $205.00 price objective on shares of Danaher in a research note on Friday, April 17th. DZ Bank began coverage on Danaher in a research report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 target price on the stock. HSBC dropped their target price on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Royal Bank Of Canada raised their price target on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research note on Wednesday, July 22nd. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $240.00 price target on shares of Danaher in a research report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $228.91.

Danaher Trading Down 0.1%

Shares of NYSE:DHR opened at $196.29 on Friday. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a market capitalization of $137.99 billion, a P/E ratio of 34.87, a price-to-earnings-growth ratio of 2.45 and a beta of 0.79. The company has a 50-day simple moving average of $187.90 and a 200 day simple moving average of $195.66. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, July 21st. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business’s revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.77 earnings per share. Sell-side analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. Danaher’s payout ratio is presently 28.42%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.